noxafil 300mg16.7ml concentrate for solution for infusion vials
merck sharp & dohme ltd - posaconazole - solution for infusion - 18mg/1ml
noxafil 300 mg concentrate for solution for infusion
merck sharp & dohme israel ltd - posaconazole - concentrate for solution for infusion - posaconazole 300 mg/vial - posaconazole - noxafil concentrate for solution for infusion is indicated for use in the treatment of the following fungal infections in adults :- invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products;- fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b;- chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole;- coccidioidomycosis in patients with disease that is refractory to amphotericin b, itraconazole or fluconazole or in patients who are intolerant of these medicinal products.- zygomycosis, in patients intolerant of, or with disease that is refractory to, alternative therapy.refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective antifungal therapy.noxafil concentrate f
kalmia latifolia- mountain laurel granule
seroyal usa - kalmia latifolia leaf (unii: 79n6542n18) (kalmia latifolia leaf - unii:79n6542n18) - kalmia latifolia leaf 3 [hp_x] - indications for the temporary relief of joint pain, back pain, sleeplessness, and stomach ache indications for the temporary relief of joint pain, back pain, sleeplessness, and stomach ache directions adults: take five granules three times daily or as recommended by your healthcare practitioner. children: take three granules and follow adult directions.
platinox-v
vitamed pharmaceutical industries ltd - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg / 1 ml - oxaliplatin - oxaliplatin in combination with 5- fluorouracil (5-fu) and folinic acid (fa) is indicated for : - adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of primary tumour. - treatment of metastatic colorectal cancer.oxaliplatin in combination with leucovorin, irinotecan and 5-fluorouracil is indicated for the first line treatment of patients with metastatic pancreatic adenocarcinoma (based on nccn guidelines, version 2.2014).
lumify solution
bausch & lomb inc - brimonidine tartrate - solution - 0.025% - brimonidine tartrate 0.025%
unituxin solution
united therapeutics corporation - dinutuximab - solution - 3.5mg - dinutuximab 3.5mg - antineoplastic agents
actemra concentrate for solution for infusion 20mgml
roche singapore pte. ltd. - tocilizumab - infusion, solution concentrate - 20mg/ml - tocilizumab 20mg/ml
keytruda solution for infusion 25mgml
msd pharma (singapore) pte. ltd. - pembrolizumab - infusion, solution concentrate - pembrolizumab 25.0 mg/ml
eperzan 30mg powder and solvent for solution for injection pre-filled pen
glaxosmithkline uk ltd - albiglutide - powder and solvent for solution for injection - 30mg
eperzan 50mg powder and solvent for solution for injection pre-filled pen
glaxosmithkline uk ltd - albiglutide - powder and solvent for solution for injection - 50mg